Galmed Pharmaceuticals (EOCN) Receivables - Other (2019 - 2026)
Galmed Pharmaceuticals' Receivables - Other was $323,000 in Q2 2026, down 25.4% from $433,000 a year earlier and down 28.4% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Receivables - Other (2019 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at Galmed Pharmaceuticals came in at $347,000, down 48.4% from FY2024.
- Receivables - Other shows a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
- In earlier years, Receivables - Other was $672,000 in FY2024 (+40.0%), $480,000 in FY2023 (-41.8%), $825,000 in FY2022 (-26.7%) and $1.13 million in FY2021 (+38.5%).
- The Q2 2026 figure marks the lowest quarterly Receivables - Other since Q4 2024.
- Compared with a year earlier, Receivables - Other was higher in six of the last eight quarters, with growth averaging 53.8%.
- The best year-over-year quarter for Receivables - Other over five years was Q1 2024 (growth of 361.8%); the worst was Q4 2022 (a decline of 97.1%).
- Per Business Quant data, EOCN's Receivables - Other in the three quarters before Q2 2026 was $451,000 (Q1 2026), $347,000 (Q4 2025) and $549,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 323,000.00 |
| Mar 31, 2026 | 451,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 447,000.00 |
| Dec 31, 2024 | 133,000.00 |
| Sep 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Sep 30, 2023 | 770,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 55,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 614,000.00 |
| Mar 31, 2022 | 843,000.00 |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 1.67 Mn |
API Access
Galmed Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();